⟵ Back to Search Results

BGB-A317-307

Active, not recruiting

A Study Tislelizumab in Combination With Chemotherapy Versus Chemotherapy in Advanced Lung Cancer.

Beigene Study ID info

BGB-A317-307

ClinicalTrials.gov ID info

NCT03594747

China Drug Trials ID info

CTR20180292

Study Overview

Sex: All

Age: 18 Years to 75 Years   (Adult, Older Adult)

No Study Documents

Study Overview

Sex: All

Age: 18 Years to 75 Years   (Adult, Older Adult)

No Study Documents